Imaging Technology

FEBRUARY 21, 2024

milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 Food and Drug Administration.

Clinic 104

Clinic Radiopharmaceuticals Nuclear Medicine Hospital 104

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc. announced that it has entered into a patent license agreement with Mayo Clinic for the rights to the PSMA Alpha-PET DoubLET platform technology for the treatment of PSMA-expressing cancers, with an initial focus on prostate.

Radiopharmaceuticals 104

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 104

AuntMinnie

DECEMBER 20, 2023

The American Roentgen Ray Society (ARRS) has named David Naeger, MD, as the recipient of its 2024 distinguished educator award. He served as associate chair for education and co-director of UCSF’s Center for Advanced Imaging Education before joining the University of Colorado.

Education 59

Education Nuclear Medicine Medical Imaging Radiology 59

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclear medicine technologists means a theranostics center may need to limit its patient volume.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105

AuntMinnie

NOVEMBER 4, 2024

reduction in average Medicare payment rates compared with 2024, the CMS has estimated there will be a 0% change to reimbursement for radiology, nuclear medicine, and radiation oncology. increase in the conversion factor from 2024, rising to $89.16 Although the 2025 MPFS calls for an overall 2.9%

Radiation Oncology 80

Radiation Oncology Nuclear Medicine Medicare Imaging 80

Imaging Technology

DECEMBER 27, 2023

Naeger, MD , as the 2024 ARRS Distinguished Educator. Dr. Naeger has disseminated to countless radiologists and other health professionals the most current scientific and clinical information regarding diagnostic imaging, image-guided intervention, and related fields. Naeger’s talks were grand rounds given throughout the United States.

Education 104

Education Nuclear Medicine Inpatient Radiology 104

Imaging Technology

JULY 31, 2024

mtaschetta-millane Wed, 07/31/2024 - 07:00 July 31, 2024 — The American Registry of Radiologic Technologists ( ARRT ) announced the three Registered Technologists (R.T.s) Wayne Stenzel is a senior MRI technologist at the Mayo Clinic in Rochester, Minnesota. who earned honors in this year’s I Am the Gold Standard program.

Nuclear Medicine 105

Nuclear Medicine Radiology Technologist Patient Care Radiation 105

AuntMinnie

APRIL 4, 2024

They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly. Hope, vice chair of clinical operations and strategy in the UCSF department of radiology, established the radioligand therapy group at the university. Theranostics is becoming a treatment option for a larger volume of cancer patients.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. The nuclear radiologist, nuclear medicine technologist, and radiation safety team are all present to administer an infusion.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 28, 2024

New imaging and treatment strategies are emerging to prolong the lives of men with metastatic castration-resistant prostate cancer (mCRPC), according to a presentation at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. Now there’s Pluvicto, she said.

Nuclear Medicine 111

Nuclear Medicine Radiation Disease Medical 111

AuntMinnie

JUNE 8, 2024

An emerging PET/CT radiotracer may be more predictive of progressive pulmonary fibrosis in interstitial lung patients than F-18 FDG PET/CT, according to research presented June 8 at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI). Comparative analysis involved PET/CT parameters of both tracers.

Nuclear Medicine 105

Nuclear Medicine Imaging Modalities Diagnose Disease 105

Imaging Technology

JANUARY 16, 2024

milla1cf Tue, 01/16/2024 - 14:37 January 16, 2024 — The Society of Nuclear Medicine and Molecular Imaging ( SNMMI ) and the European Association of Nuclear Medicine (EANM) have issued a new procedure standard/practice guideline for estrogen receptor imaging of breast cancer patients using FES PET.

Nuclear Medicine 52

Nuclear Medicine Imaging Image Interpretation Diagnose 52

AuntMinnie

SEPTEMBER 20, 2024

Pluvicto (lutetium-177 [Lu-177] prostate-specific membrane antigen [PSMA]-617) appears to perform as effectively in prostate cancer patients in “real-world” settings as it did in clinical trials prior to its approval, according to clinicians at the Johns Hopkins Theranostics Center in Baltimore, MD.

Nuclear Medicine 111

Nuclear Medicine Clinic Hospital IT 111

Imaging Technology

JULY 9, 2024

The Company is a recognized leader throughout the nuclear medicine and oncology communities, having a strong reputation grounded in successful innovation, execution and dedicated service on behalf of patient health,” he added. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A.,

Diagnostic 105

Diagnostic Radiopharmaceuticals Nuclear Medicine Magnetic Resonance Imaging 105

AuntMinnie

JUNE 11, 2024

“This is a potentially practice-changing trial,” said Oliver Sartor, MD, a medical oncologist and director of radiopharmaceutical trials at the Mayo Clinic in Rochester, MN. He presented the abstract on behalf of first author Ken Herrmann, MD, chair of nuclear medicine at the University Hospital Essen in Essen, Germany.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiographer Radiograph 122

Imaging Technology

JUNE 24, 2024

milla1cf Mon, 06/24/2024 - 20:34 June 24, 2024 — The Radiological Society of North America ( RSNA ) announced the 2023 impact factors today for its suite of journals. For more information: RSNA.org/journals Monday, June 24, 2024 - 20:34 If you enjoy this content, please share it with a colleague Luker, M.D., and 491 citations.

Nuclear Medicine 105

Nuclear Medicine Radiographer Radiograph Radiographer 105

AuntMinnie

JUNE 6, 2024

Hermes CEO Tom Francke said the collaboration will support dosimetry planning and verification for theranostics, as well as "seamless user access" across all clinical aspects of nuclear medicine.

Nuclear Medicine 40

Nuclear Medicine Medical IT Clinic 40

Imaging Technology

JUNE 12, 2024

The company reports it is a worldwide leader in the clinical use of AI to improve diagnoses with one of the largest global deployments to enhance early breast cancer detection and in the evaluation of brain disorders. More information: www.SimonMed.com Wednesday, June 12, 2024 - 11:45

Disease 116

Disease Magnetic Resonance Imaging Nuclear Medicine Imaging 116

Imaging Technology

FEBRUARY 9, 2024

milla1cf Fri, 02/09/2024 - 09:17 February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before clinical symptoms arise, according to research published in the February issue of The Journal of Nuclear Medicine.

PET Scan 115

PET Scan Nuclear Medicine Disease Clinic 115

Imaging Technology

NOVEMBER 1, 2024

tim.hodson Fri, 11/01/2024 - 12:58 Blue Earth Therapeutics Ltd, recently announced further positive developments for its novel investigational radioligand therapies. The Phase 2 clinical trial of Lutetium ( 177 Lu) rhPSMA-10.1 Journal of Nuclear Medicine (2024). Injection was completed in July.

Nuclear Medicine 52

Nuclear Medicine Radiation Radiopharmaceuticals Clinic 52

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. The nuclear radiologist, nuclear medicine technologist, and radiation safety team are all present to administer an infusion.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

AuntMinnie

OCTOBER 16, 2024

In a review of studies that included 409 patients, the technique was superior to standard-of-care FDG-PET/CT and could potentially serve as an alternative to invasive tissue sampling procedures, nuclear medicine researchers suggested.

Nuclear Medicine 89

Nuclear Medicine Diagnostic Ultrasound Clinic 89

Imaging Technology

JUNE 11, 2024

milla1cf Tue, 06/11/2024 - 18:41 June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis, a condition referred to as the “Alzheimer’s disease of the heart.” This research was presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.

Disease 94

Disease Imaging Nuclear Medicine Diagnose 94

AuntMinnie

JUNE 9, 2024

Jean-Luc Urbain, MD, PhD, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Urbain, a professor of radiology and nuclear medicine, has served in multiple roles within SNMMI, in addition to his most recent post as vice president-elect. Jean-Luc Urbain, MD, PhD. “As

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Government Education 40

AuntMinnie

JUNE 10, 2024

Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He will be honored at the SNMMI's annual meeting in Toronto. Evans earned his PhD in organic chemistry from the Scripps Research Institute.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Pharmaceutical Clinic 40

AuntMinnie

FEBRUARY 1, 2024

The American Roentgen Ray Society (ARRS) is awarding its two 2024 ARRS Scholarships to Ian Mark, MD, of Mayo Clinic Minnesota and Evan Calabrese, MD, PhD, of Duke University Medical Center. Mark completed his diagnostic radiology residency at Mayo Clinic, where he was chief resident. Ian Mark, MD. Image courtesy of the ARRS.

Nuclear Medicine 52

Nuclear Medicine Clinic Diagnostic Hospital 52

Imaging Technology

NOVEMBER 8, 2024

tim.hodson Fri, 11/08/2024 - 12:57 Nov. 4, 2024 – Shared Medical Services, Inc. SMS) and Nebraska Medicine recently announced the deployment of the Philips Mobile MR 5300 BlueSeal magnet. Nebraska Medicine will be the first to bring the Mobile MR 5300 into its clinical operations.

Medical 59

Medical Imaging Nuclear Medicine Medical Device 59

Imaging Technology

APRIL 24, 2024

The findings were published in Clinical Nuclear Medicine. Singhal said before the technique can be used routinely in a clinical setting, it must be validated on a larger sample size. It’s very exciting that our novel approach worked and correlated so strongly with clinical measures we assessed,” he said. “It

PET Scan 102

PET Scan Disease Nuclear Medicine Clinic 102

Imaging Technology

DECEMBER 4, 2023

He currently serves as vice chair for research in the Department of Radiology at Weill Cornell Medicine , where he holds professorships in radiology and neuroscience. Gupta begins his appointment as chair on Feb. While at Weill Cornell, Gupta led a research program to evaluate emerging neuroimaging techniques that may improve patient care.

Radiologist 105

Radiologist Radiology Nuclear Medicine Education 105

Imaging Technology

JUNE 20, 2024

christine.book Thu, 06/20/2024 - 08:24 June 20, 2024 — The Society for Imaging Informatics in Medicine ( SIIM ) is gearing up for its SIIM24 Annual Meeting and InformaticsTECH Expo , “Making Waves in Imaging Informatics,” set for June 27-29 in National Harbor, MD, at the Gaylord National Resort and Convention Center.

Imaging 111

Imaging Education Nuclear Medicine Medical 111

AuntMinnie

JUNE 11, 2024

Alpha-emitting astatine-211 (At-211) may open the door to new targeted radioimmunotherapy for treating blood cancer, according to research presented June 10 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Toronto. The studies support further clinical investigation.

Nuclear Medicine 105

Nuclear Medicine Disease Radiation Clinic 105

Imaging Technology

JUNE 20, 2024

For the practice of precision care in molecular imaging and nuclear medicine, this begins with the production of radioisotopes for use in diagnostic tracers, which are administered to patients, attach to specific biomarkers, and release radioactive emissions to provide clinicians detailed molecular information unique to each patient.

Healthcare 104

Healthcare Healthcare Nuclear Medicine Computed Tomography 104

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

Imaging Technology

MAY 15, 2024

milla1cf Wed, 05/15/2024 - 19:01 May 15, 2024 — Heart disease is the leading cause of mortality in the U.S., What’s more, the researchers found that combining all the factors together (including clinical data like age and medical history) was a better predictor of death than any one factor alone.

Disease 105

Disease Computed Tomography Nuclear Medicine Clinic 105

AuntMinnie

JUNE 11, 2024

An animal study shows the feasibility of an approach in colon cancer that simultaneously uses alpha- and beta-emitting isotopes to target and kill cancer cells, according to a study presented June 11 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. she concluded.

Nuclear Medicine 111

Nuclear Medicine Radiation Imaging Clinic 111

Imaging Technology

OCTOBER 4, 2024

tim.hodson Fri, 10/04/2024 - 10:51 Oct. 3, 2024 — GE HealthCare’s MIM Software has announced it received 510(k) clearance from the U.S. Traditionally, the Monte Carlo technique has been considered too slow for clinical use, taking up to several hours or more to complete calculations.

Radiopharmaceuticals 52

Radiopharmaceuticals Nuclear Medicine Radiation Healthcare 52